News

In a double-blind, active-controlled Phase II study of 480 randomised subjects, the safety, tolerability and immunogenicity of a single 15microgram dose or 60microgram dose (per strain) of trivalent

Applied BioCode’s Barcoded Magnetic Beads digital multiplexing technology, along with the BioCode-1000 Analyzer for barcode and fluorescence detection, results in a flexible digital multiplexing platform suited for a

Roche’s T-emerge Phase III clinical trials are designed as multicenter, multi-country, randomized, controlled (active or placebo), double-blind and open studies. Over 6,000 patients will be enrolled in the

Sanofi-aventis has posted business net income of EUR2.43bn, or E1.86 per diluted share, compared to EUR2.21bn, or EUR1.70 per diluted share, for the prior year period. Business operating

Oncos Therapeutics said that after treating 200 late stage cancer patients since 2007 with safety and efficacy results, it has selected its modified oncolytic adenovirus CGTG-102 as its

pSivida’s Iluvien is an injectable, non-erodable, intravitreal implant for the treatment of DME, a potentially blinding condition that affects approximately one million people in the US. Iluvien is

EyeGate claimed that it is the first company to conduct multiple controlled clinical trials to assess the safety and efficacy of iontophoresis technology to deliver therapeutics into the

Richard Clark, currently chairman, president and CEO, is expected to continue leading the company as chairman and CEO. Kenneth Frazier, currently president of the Global Human Health worldwide

The SFDA has identified deception and avoidance of regulatory inspection at Jiangsu Yanshen during the second half of 2008 in the production of certain batches of human use